- Home
- / Sihuan Pharmaceutical
Sihuan Pharmaceutical
Stock Price
$0.7
2024-10-29
Market Capitalization
$6.6 B
2024-10-29
Revenue
¥2.6 B
FY, 2025
Sihuan Pharmaceutical Summary
Company Summary
- Overview
- Hainan Sihuan Pharmaceutical (四环医药) is a company that develops medical drugs to treat oncology, diabetes, cardiovascular, CNS, and other diseases. It also specializes in aesthetic medicine, pharmaceutical production, food for special medical purpose (FSMP), and other areas.
- Type
- Public
- Status
- Active
- Founded
- 2001
- HQ
- CN | view all locations
- Website
- https://sihuanpharm.com
- Cybersecurity rating
- ESG rating
Table of Contents
LocationsView all
1 location detected
Beijing Shi HQ
China
Chaoyang Rd Side Rd, Shi Li Pu, Chaoyang Qu
Sihuan Pharmaceutical Financials
Summary Financials
- Revenue (FY, 2025)
- ¥2.6B
- Gross profit (FY, 2025)
- ¥2.0B
- Net income (FY, 2025)
- ¥185.4M
- Cash (FY, 2025)
- ¥3.6B
- EBIT (FY, 2025)
- ¥536.9M
- Enterprise value
- $4.0B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026